Crispr Therapeutics shares owned by Bank Julius Baer & Co. Ltd, Zurich
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bank Julius Baer & Co. Ltd, Zurich
from 13F filings
Historical chart of Bank Julius Baer & Co. Ltd, Zurich investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bank Julius Baer & Co. Ltd, Zurich consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bank Julius Baer & Co. Ltd, Zurich
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.0k | 130 | 61.54 |
| 2023-09-30 | $901k | 20k | 45.38 |
| 2023-06-30 | $361k | 6.4k | 56.06 |
| 2023-03-31 | $59k | 1.3k | 45.31 |
| 2022-12-31 | $39k | 957 | 40.75 |
| 2022-09-30 | $1.0M | 16k | 65.35 |
| 2022-06-30 | $930k | 15k | 60.78 |
| 2022-03-31 | $925k | 15k | 62.77 |
| 2021-12-31 | $264k | 3.5k | 75.78 |
| 2020-12-31 | $1.5M | 10k | 153.11 |